glp-1 drugs alzheimer's failed to slow in two big clinical trials Alzheimer's disease: Semaglutide use linked

The aids are nasty and uncaring

At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits

The steps of the non-oxidative branch of the PPP are reversible and serve to funnel intermediates, such as F6P and G3P, between glycolysis and the PPP

Carnitine and/or acetylcarnitine deficiency as a cause of higher levels of ammonia

Most people notice increased energy, improved mood, and mental clarity within a few days, though results vary depending on your current B12 levels